Polar Capital Holdings Plc Sells 676,377 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX)

Polar Capital Holdings Plc lessened its holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 41.9% during the third quarter, HoldingsChannel.com reports. The firm owned 939,012 shares of the company’s stock after selling 676,377 shares during the period. Polar Capital Holdings Plc’s holdings in MoonLake Immunotherapeutics were worth $53,524,000 as of its most recent SEC […]

Related Keywords

Moonlake Immunotherapeutics ,Kristian Reich ,Silva Jorge Santos ,William Blair ,Citigroup ,Moonlake Immunotherapeutics Company Profile ,Pricet Rowe Associates Inc ,Securities Exchange Commission ,Citadel Advisors ,Polar Capital Holdings Plc ,Wolfe Research ,Free Report ,Capital Holdings Plc ,Asset Management ,Capital Partners ,Pricet Rowe Associates ,Exchange Commission ,Get Free Report ,Visit Holdingschannel ,Nasdaq Mltx ,Mltx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,